Skip to main content
Top
Published in: Journal of Neuro-Oncology 1/2016

01-08-2016 | Clinical Study

Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis

Authors: Mathieu Boone, Martine Roussel, Bruno Chauffert, Daniel Le Gars, Olivier Godefroy

Published in: Journal of Neuro-Oncology | Issue 1/2016

Login to get access

Abstract

Cognitive impairment has been reported in 27–83 % of adults with World Health Organization (WHO) grade I–III glioma. However, the few studies in this field used different methods for cognitive assessment. The objective of the present study was to establish the prevalence of cognitive impairment in patients with WHO grade I–III primary brain tumors and determine the effect sizes of a comprehensive battery of tests. This study used a comprehensive neuropsychological battery to examine 27 patients. To control for false positives, prevalence was estimated from the overall neuropsychological score. Size effects were determined using Cohen’s d. Cognitive impairment was observed in 51.9 % (95 % CI 33−70.7 %) of the patients; the impairment affected action speed (38.5 %), cognitive (33 %) and behavioral (21.7 %) executive functions, oral expression (29.6 %), episodic memory (29.6 %) and visuoconstructive abilities (19.2 %). The largest effect sizes (d ≥ 1.645) were observed for the Digit Symbol Substitution test, global hypoactivity, free recall, Stroop time, the Boston Naming test (BNT), the Trail Making test B (TMTB), verbal fluency and the Rey–Osterrieth Complex Figure Test. Four of these scores (global hypoactivity, the Digit Symbol Substitution test, the TMTB perseveration, and the BNT) were combined to make a shortened battery (AUC 0.872; 95 % CI 0.795–0.949). The overall neuropsychological score was the sole factor associated with the functional outcome. Our results suggest that about half of survivors with a grade I–III primary brain tumor suffer from cognitive impairment. Tests with a large effect size should be included in future large-scale studies.
Literature
1.
go back to reference Zouaoui S, Rigau V, Mathieu-Daudé H, Darlix A, Bessaoud F, Fabbro-Peray P et al (2012) French brain tumor database: general results on 40,000 cases, main current applications and future prospects. Neurochirurgie 58:4–13CrossRefPubMed Zouaoui S, Rigau V, Mathieu-Daudé H, Darlix A, Bessaoud F, Fabbro-Peray P et al (2012) French brain tumor database: general results on 40,000 cases, main current applications and future prospects. Neurochirurgie 58:4–13CrossRefPubMed
2.
go back to reference Ostrom QT, Gittelman H, Liao P, Liu M, Blanda R, Kromer C et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16:iv1–iv63CrossRefPubMedPubMedCentral Ostrom QT, Gittelman H, Liao P, Liu M, Blanda R, Kromer C et al (2014) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. Neuro Oncol 16:iv1–iv63CrossRefPubMedPubMedCentral
3.
go back to reference Louis D, Ohgaki H, Wiestler O, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedPubMedCentral Louis D, Ohgaki H, Wiestler O, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109CrossRefPubMedPubMedCentral
4.
go back to reference Klein M, Heimans JJ, Aaronson NK, Van der Ploeg HM, Grit J, Muller M et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361–1368CrossRefPubMed Klein M, Heimans JJ, Aaronson NK, Van der Ploeg HM, Grit J, Muller M et al (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 360:1361–1368CrossRefPubMed
5.
go back to reference Pahlson A, Ek L, Ahlstrom G, Smits A (2003) Pitfalls in the assessment of disability in individuals with low-grade gliomas. J Neurooncol 65:149–158CrossRefPubMed Pahlson A, Ek L, Ahlstrom G, Smits A (2003) Pitfalls in the assessment of disability in individuals with low-grade gliomas. J Neurooncol 65:149–158CrossRefPubMed
6.
go back to reference Ek L, Almkvist O, Kristoffersen Wiberg M, Stragliotto G, Smits A (2010) Early cognitive impairment in a subset of patients with presumed low-grade glioma. Neurocase 16:503–511CrossRefPubMed Ek L, Almkvist O, Kristoffersen Wiberg M, Stragliotto G, Smits A (2010) Early cognitive impairment in a subset of patients with presumed low-grade glioma. Neurocase 16:503–511CrossRefPubMed
7.
go back to reference Habets EJ, Taphoorn MJ, Nederend S, Klein M, Delgadillo D, Hoang-Xuan K et al (2014) Quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. J Neurooncol 116:161–168CrossRefPubMed Habets EJ, Taphoorn MJ, Nederend S, Klein M, Delgadillo D, Hoang-Xuan K et al (2014) Quality of life and cognitive functioning in long-term anaplastic oligodendroglioma and oligoastrocytoma survivors. J Neurooncol 116:161–168CrossRefPubMed
8.
go back to reference Van Loon E, Heijenbrok-Kal M, Van Loon W, Van den Bent MJ, Vincent AJ, de Koning I et al (2015) Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: a systematic review. J Rehabil Med 47:481–488CrossRefPubMed Van Loon E, Heijenbrok-Kal M, Van Loon W, Van den Bent MJ, Vincent AJ, de Koning I et al (2015) Assessment methods and prevalence of cognitive dysfunction in patients with low-grade glioma: a systematic review. J Rehabil Med 47:481–488CrossRefPubMed
9.
go back to reference Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629CrossRefPubMed Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol 19:623–629CrossRefPubMed
10.
go back to reference Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–708CrossRefPubMed Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703–708CrossRefPubMed
11.
go back to reference American Psychological Association (2010) Publication manual of the American Psychological Association, 6th edn. American Psychological Association, Washington, DC American Psychological Association (2010) Publication manual of the American Psychological Association, 6th edn. American Psychological Association, Washington, DC
13.
go back to reference Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479CrossRefPubMed Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479CrossRefPubMed
14.
go back to reference Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870CrossRefPubMed Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870CrossRefPubMed
15.
go back to reference Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, p 196 Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM (ed) Evaluation of chemotherapeutic agents. Columbia University Press, New York, p 196
16.
go back to reference Godefroy O, Duhamel A, Leclerc X, Saint Michel T, Hénon H, Leys D (1998) Brain–behaviour relationships. Some models and related statistical procedures for the study of brain-damaged patients. Brain 121:1545–1556CrossRefPubMed Godefroy O, Duhamel A, Leclerc X, Saint Michel T, Hénon H, Leys D (1998) Brain–behaviour relationships. Some models and related statistical procedures for the study of brain-damaged patients. Brain 121:1545–1556CrossRefPubMed
17.
go back to reference Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P et al (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972CrossRefPubMedPubMedCentral Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P et al (1992) Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry 55:967–972CrossRefPubMedPubMedCentral
18.
go back to reference Godefroy O, Azouvi P, Robert P, Roussel M, LeGall D, Meulemans T, GREFEX Study Group (2010) Dysexecutive syndrome: diagnostic criteria and validation study. Ann Neurol 68(6):855–864CrossRefPubMed Godefroy O, Azouvi P, Robert P, Roussel M, LeGall D, Meulemans T, GREFEX Study Group (2010) Dysexecutive syndrome: diagnostic criteria and validation study. Ann Neurol 68(6):855–864CrossRefPubMed
19.
go back to reference American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
20.
go back to reference Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini-mental state: a practical method for grading the cognition state of the patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed Folstein MF, Folstein SE, Mc Hugh PR (1975) Mini-mental state: a practical method for grading the cognition state of the patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMed
21.
go back to reference Kalafat M, Hugonot-Diener L, Poitrenaud J (2003) Standardisation et etalonnage francais du mini mental state (MMS) version GRECO. Revue de Neuropsychologie 13:209–236 Kalafat M, Hugonot-Diener L, Poitrenaud J (2003) Standardisation et etalonnage francais du mini mental state (MMS) version GRECO. Revue de Neuropsychologie 13:209–236
22.
go back to reference Raven JC (1965). Guide to using the coloured progressive matrices. Lewis Publisher, London Raven JC (1965). Guide to using the coloured progressive matrices. Lewis Publisher, London
23.
go back to reference Fuhrer R, Rouillon F (1989) La version française de l’échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l’échelle d’autoévaluation. Psychiatr Psychobiol 4(3):136–166 Fuhrer R, Rouillon F (1989) La version française de l’échelle CES-D (Center for Epidemiologic Studies-Depression Scale). Description et traduction de l’échelle d’autoévaluation. Psychiatr Psychobiol 4(3):136–166
24.
go back to reference Goldberg D (1988) Detecting anxiety and depression in general medical settings. Br Med J 297:897–899CrossRef Goldberg D (1988) Detecting anxiety and depression in general medical settings. Br Med J 297:897–899CrossRef
25.
go back to reference De Renzi E, Faglioni P (1978) Normative data and screening power of a shortened version of the token test. Cortex 14(1):41–49CrossRefPubMed De Renzi E, Faglioni P (1978) Normative data and screening power of a shortened version of the token test. Cortex 14(1):41–49CrossRefPubMed
26.
go back to reference Colombo (1992) Adaptation française du test de dénomination de Boston, Versions abrégées. Revue europèenne de psychologie appliquée. 42 (1): 67–71 Colombo (1992) Adaptation française du test de dénomination de Boston, Versions abrégées. Revue europèenne de psychologie appliquée. 42 (1): 67–71
28.
go back to reference Rey A (1959) Test de copie d’une figure complexe. Editions du centre de psychologie appliquée, Paris Rey A (1959) Test de copie d’une figure complexe. Editions du centre de psychologie appliquée, Paris
29.
go back to reference Wechsler D (1997) Wechsler Adult Intelligence Scale, 3rd edn. Psychological Corporation, San Antonio Wechsler D (1997) Wechsler Adult Intelligence Scale, 3rd edn. Psychological Corporation, San Antonio
30.
go back to reference Van der Linden M, Coyette F, Poitrenaud J, et les membres du GREMEM (2004). L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). In: Van der Linden M, Adam S, Agniel A, les membres du GREMEM (eds) L’évaluation des troubles de la mémoire. Présentation de quatre tests de mémoire épisodique. Solal, Marseille, pp 25–47 Van der Linden M, Coyette F, Poitrenaud J, et les membres du GREMEM (2004). L’épreuve de rappel libre/rappel indicé à 16 items (RL/RI-16). In: Van der Linden M, Adam S, Agniel A, les membres du GREMEM (eds) L’évaluation des troubles de la mémoire. Présentation de quatre tests de mémoire épisodique. Solal, Marseille, pp 25–47
31.
go back to reference Baddeley AD, Emslie H, Nimmo-Smith I (1994) Doors and people: a test of visual and verbal recall and recognition. Thames Valley Test Company, Suffolk Baddeley AD, Emslie H, Nimmo-Smith I (1994) Doors and people: a test of visual and verbal recall and recognition. Thames Valley Test Company, Suffolk
32.
go back to reference Godefroy O, Leclercq C, Roussel M, Moroni C, Quaglino V, Beaunieux H et al (2012) French adaptation of the vascular cognitive impairment harmonization standards: the Grecog-Vasc study. Int J Stroke 7:362–363CrossRefPubMed Godefroy O, Leclercq C, Roussel M, Moroni C, Quaglino V, Beaunieux H et al (2012) French adaptation of the vascular cognitive impairment harmonization standards: the Grecog-Vasc study. Int J Stroke 7:362–363CrossRefPubMed
33.
go back to reference Godefroy O, Gibbons L, Diouf M, Nyenhuis D, Roussel M, Black S et al (2014) Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials. Cortex 54:51–62CrossRefPubMedPubMedCentral Godefroy O, Gibbons L, Diouf M, Nyenhuis D, Roussel M, Black S et al (2014) Validation of an integrated method for determining cognitive ability: implications for routine assessments and clinical trials. Cortex 54:51–62CrossRefPubMedPubMedCentral
34.
go back to reference Godefroy O, Roussel M, Leclerc X, Leys D (2009) Deficit of episodic memory: anatomy and related patterns in stroke patients. Eur Neurol 61:223–229CrossRefPubMed Godefroy O, Roussel M, Leclerc X, Leys D (2009) Deficit of episodic memory: anatomy and related patterns in stroke patients. Eur Neurol 61:223–229CrossRefPubMed
35.
go back to reference Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale
36.
go back to reference DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845CrossRefPubMed
37.
go back to reference Brown PD (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. Am J Clin Oncol 21:2519–2524CrossRef Brown PD (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination. Am J Clin Oncol 21:2519–2524CrossRef
38.
go back to reference Meyers CA, Wefel JS (2003) The use of the MiniMental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557–3558CrossRefPubMed Meyers CA, Wefel JS (2003) The use of the MiniMental State Examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity. J Clin Oncol 21:3557–3558CrossRefPubMed
39.
go back to reference Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC et al (2014) Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. J Clin Oncol 32(6):535–541CrossRefPubMedPubMedCentral Prabhu RS, Won M, Shaw EG, Hu C, Brachman DG, Buckner JC et al (2014) Effect of the addition of chemotherapy to radiotherapy on cognitive function in patients with low-grade glioma: secondary analysis of RTOG 98-02. J Clin Oncol 32(6):535–541CrossRefPubMedPubMedCentral
40.
go back to reference Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials for patients with CNS tumors. J Clinical Oncol 24:1305–1309CrossRef Meyers CA, Brown PD (2006) Role and relevance of neurocognitive assessment in clinical trials for patients with CNS tumors. J Clinical Oncol 24:1305–1309CrossRef
41.
go back to reference Lageman SK, Cerhan JH, Locke DE, Anderson SK, Wu W, Brown PD (2010) Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trails. J Neurooncol 96(2):271–276CrossRefPubMed Lageman SK, Cerhan JH, Locke DE, Anderson SK, Wu W, Brown PD (2010) Comparing neuropsychological tasks to optimize brief cognitive batteries for brain tumor clinical trails. J Neurooncol 96(2):271–276CrossRefPubMed
42.
go back to reference Sichez N, Chatelier G, Poisson M, Delattre JY (1996) Gliomes sus-tentoriels: étude neuropsychologique des survivants à long terme. Rev Neurol 152:261–266PubMed Sichez N, Chatelier G, Poisson M, Delattre JY (1996) Gliomes sus-tentoriels: étude neuropsychologique des survivants à long terme. Rev Neurol 152:261–266PubMed
Metadata
Title
Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis
Authors
Mathieu Boone
Martine Roussel
Bruno Chauffert
Daniel Le Gars
Olivier Godefroy
Publication date
01-08-2016
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 1/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-016-2152-7

Other articles of this Issue 1/2016

Journal of Neuro-Oncology 1/2016 Go to the issue